Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$2.65 - $3.81 $365,188 - $525,044
-137,807 Reduced 79.6%
35,316 $104,000
Q4 2022

Feb 14, 2023

SELL
$3.38 - $4.22 $17,914 - $22,366
-5,300 Reduced 2.97%
173,123 $631,000
Q3 2022

Nov 14, 2022

SELL
$3.43 - $5.83 $256,714 - $436,340
-74,844 Reduced 29.55%
178,423 $642,000
Q2 2022

Aug 15, 2022

BUY
$4.41 - $5.69 $196,042 - $252,943
44,454 Added 21.29%
253,267 $1.34 Million
Q1 2022

May 16, 2022

BUY
$4.81 - $6.99 $798,955 - $1.16 Million
166,103 Added 388.91%
208,813 $1.15 Million
Q4 2021

Feb 14, 2022

BUY
$5.97 - $7.93 $254,978 - $338,690
42,710 New
42,710 $291,000
Q3 2021

Nov 15, 2021

SELL
$4.79 - $6.68 $288,578 - $402,443
-60,246 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$5.35 - $6.35 $322,316 - $382,562
60,246 New
60,246 $356,000
Q1 2021

May 17, 2021

SELL
$5.68 - $7.87 $306,322 - $424,429
-53,930 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$5.25 - $8.56 $283,132 - $461,640
53,930 New
53,930 $373,000
Q1 2019

May 15, 2019

SELL
$5.16 - $6.85 $368,284 - $488,905
-71,373 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$4.89 - $7.16 $78,880 - $115,497
-16,131 Reduced 18.43%
71,373 $362,000
Q3 2018

Nov 14, 2018

SELL
$6.89 - $7.78 $703,889 - $794,812
-102,161 Reduced 53.86%
87,504 $631,000
Q2 2018

Aug 14, 2018

SELL
$5.19 - $7.25 $393,697 - $549,963
-75,857 Reduced 28.57%
189,665 $1.27 Million
Q1 2018

May 15, 2018

BUY
$3.56 - $5.74 $945,258 - $1.52 Million
265,522 New
265,522 $1.46 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $329M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.